Cargando…

Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction

BACKGROUND: Subclinical left ventricular dysfunction detected by 2‐dimensional global longitudinal strain post breast radiotherapy has been described in patients with breast cancer. We hypothesized that left ventricular dysfunction postradiotherapy may be site specific, based on differential segment...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Siddharth J., Tang, Simon, Byth, Karen, Stefani, Luke, Lo, Queenie, Otton, James, Jameson, Michael, Tran, David, Batumalai, Vikneswary, Holloway, Lois, Delaney, Geoff P., Koh, Eng‐Siew, Thomas, Liza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174310/
https://www.ncbi.nlm.nih.gov/pubmed/33749308
http://dx.doi.org/10.1161/JAHA.120.019476
_version_ 1783702881635926016
author Trivedi, Siddharth J.
Tang, Simon
Byth, Karen
Stefani, Luke
Lo, Queenie
Otton, James
Jameson, Michael
Tran, David
Batumalai, Vikneswary
Holloway, Lois
Delaney, Geoff P.
Koh, Eng‐Siew
Thomas, Liza
author_facet Trivedi, Siddharth J.
Tang, Simon
Byth, Karen
Stefani, Luke
Lo, Queenie
Otton, James
Jameson, Michael
Tran, David
Batumalai, Vikneswary
Holloway, Lois
Delaney, Geoff P.
Koh, Eng‐Siew
Thomas, Liza
author_sort Trivedi, Siddharth J.
collection PubMed
description BACKGROUND: Subclinical left ventricular dysfunction detected by 2‐dimensional global longitudinal strain post breast radiotherapy has been described in patients with breast cancer. We hypothesized that left ventricular dysfunction postradiotherapy may be site specific, based on differential segmental radiotherapy dose received. METHODS AND RESULTS: Transthoracic echocardiograms were performed at baseline, 6 weeks, and 12 months postradiotherapy on 61 chemotherapy‐naïve women with left‐sided breast cancer undergoing tangential breast radiotherapy. Radiation received within basal, mid, and apical regions for the 6 left ventricular walls was quantified from the radiotherapy treatment planning system. Anterior, anteroseptal, and anterolateral walls received the highest radiation doses, while inferolateral and inferior walls received the lowest. There was a progressive increase in the radiation dose received from basal to apical regions. At 6 weeks, the most significant percentage deterioration in strain was seen in the apical region, with greatest reductions in the anterior wall followed by the anteroseptal and anterolateral walls, with a similar pattern persisting at 12 months. There was a within‐patient dose–response association between the segment‐specific percentage deterioration in strain at 6 weeks and 12 months and the radiation dose received. CONCLUSIONS: Radiotherapy for left‐sided breast cancer causes differential segmental dysfunction, with myocardial segments that receive the highest radiation dose demonstrating greatest strain impairment. Percentage deterioration in strain observed 6 weeks postradiotherapy persisted at 12 months and demonstrated a dose–response relationship with radiotherapy dose received. Radiotherapy‐induced subclinical cardiac dysfunction is of importance because it could be additive to chemotherapy‐related cardiotoxicity in patients with breast cancer. Long‐term outcomes in patients with asymptomatic strain reduction require further investigation.
format Online
Article
Text
id pubmed-8174310
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81743102021-06-11 Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction Trivedi, Siddharth J. Tang, Simon Byth, Karen Stefani, Luke Lo, Queenie Otton, James Jameson, Michael Tran, David Batumalai, Vikneswary Holloway, Lois Delaney, Geoff P. Koh, Eng‐Siew Thomas, Liza J Am Heart Assoc Original Research BACKGROUND: Subclinical left ventricular dysfunction detected by 2‐dimensional global longitudinal strain post breast radiotherapy has been described in patients with breast cancer. We hypothesized that left ventricular dysfunction postradiotherapy may be site specific, based on differential segmental radiotherapy dose received. METHODS AND RESULTS: Transthoracic echocardiograms were performed at baseline, 6 weeks, and 12 months postradiotherapy on 61 chemotherapy‐naïve women with left‐sided breast cancer undergoing tangential breast radiotherapy. Radiation received within basal, mid, and apical regions for the 6 left ventricular walls was quantified from the radiotherapy treatment planning system. Anterior, anteroseptal, and anterolateral walls received the highest radiation doses, while inferolateral and inferior walls received the lowest. There was a progressive increase in the radiation dose received from basal to apical regions. At 6 weeks, the most significant percentage deterioration in strain was seen in the apical region, with greatest reductions in the anterior wall followed by the anteroseptal and anterolateral walls, with a similar pattern persisting at 12 months. There was a within‐patient dose–response association between the segment‐specific percentage deterioration in strain at 6 weeks and 12 months and the radiation dose received. CONCLUSIONS: Radiotherapy for left‐sided breast cancer causes differential segmental dysfunction, with myocardial segments that receive the highest radiation dose demonstrating greatest strain impairment. Percentage deterioration in strain observed 6 weeks postradiotherapy persisted at 12 months and demonstrated a dose–response relationship with radiotherapy dose received. Radiotherapy‐induced subclinical cardiac dysfunction is of importance because it could be additive to chemotherapy‐related cardiotoxicity in patients with breast cancer. Long‐term outcomes in patients with asymptomatic strain reduction require further investigation. John Wiley and Sons Inc. 2021-03-20 /pmc/articles/PMC8174310/ /pubmed/33749308 http://dx.doi.org/10.1161/JAHA.120.019476 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Trivedi, Siddharth J.
Tang, Simon
Byth, Karen
Stefani, Luke
Lo, Queenie
Otton, James
Jameson, Michael
Tran, David
Batumalai, Vikneswary
Holloway, Lois
Delaney, Geoff P.
Koh, Eng‐Siew
Thomas, Liza
Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction
title Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction
title_full Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction
title_fullStr Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction
title_full_unstemmed Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction
title_short Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction
title_sort segmental cardiac radiation dose determines magnitude of regional cardiac dysfunction
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174310/
https://www.ncbi.nlm.nih.gov/pubmed/33749308
http://dx.doi.org/10.1161/JAHA.120.019476
work_keys_str_mv AT trivedisiddharthj segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT tangsimon segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT bythkaren segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT stefaniluke segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT loqueenie segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT ottonjames segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT jamesonmichael segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT trandavid segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT batumalaivikneswary segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT hollowaylois segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT delaneygeoffp segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT kohengsiew segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction
AT thomasliza segmentalcardiacradiationdosedeterminesmagnitudeofregionalcardiacdysfunction